Pharmalot By Ed Silverman After a long battle, Pfizer drops the price of its Prevnar vaccine to humanitarian groups
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Is the 21st Century Cures bill in doubt over drug prices?
Pharmalot By Ed Silverman Doctors Without Borders chastises Pfizer for refusing to lower vaccine price
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: To avoid scandal, Novartis CEO advises companies not to hire rulebreakers
Pharmalot By Ed Silverman FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill
Pharmalot By Ed Silverman FDA reviewers question Pfizer study about safety of its Chantix smoking cessation pill
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Pfizer CEO says Clinton drug pricing plan is ‘very negative’
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Are concerns about spending on orphan drugs overblown?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Docs disciplined for misconduct still paid by pharma to be speakers, advisers
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: India wants you to know its drugs are safe and effective
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: North Korea’s Neo-Viagra has the same ingredient as the real thing
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Bristol-Myers cancer drug misses main goal in late-stage study